# iBio, Inc.: filings

IBIO · Nasdaq · CIK 1420720 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/ibio.md) · [Financials](/companies/ibio/financials.md) · [Filings](/companies/ibio/filings.md) · [Insiders](/companies/ibio/insiders.md)

## Reports and events: 361 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 211, 4 209, 10-Q 53, 3 30, 424B3 30, 424B5 27, DEFA14A 26, SC 13D/A 23, CORRESP 21, SCHEDULE 13G/A 21, UPLOAD 21, DEF 14A 20, EFFECT 20, 10-K 18, SCHEDULE 13G 14, PRE 14A 12, 4/A 11, S-1 10, S-3 10, NT 10-Q 9, SC 13G 8, 10-K/A 7, D 7, NT 10-K 7, 8-K/A 6, S-1/A 6, S-3/A 6, S-8 6, 10-Q/A 4, ARS 4, SC 13G/A 4, FWP 3, SC 13D 3, 424B4 2, 8-A12B 2, SC TO-C 2, 25 1, CERT 1, CERTNYS 1, CT ORDER 1, DEFR14A 1, POS AM 1, RW 1, SC TO-I 1, SC TO-I/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-19 | 20:16 ET | [8-K](/filings/0001420720-26-000032.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001420720-26-000032 |
| 2026-10-13 | 12:25 ET | [8-K](/filings/0001420720-26-000030.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001420720-26-000030 |
| 2026-09-14 | 20:16 ET | [8-K](/filings/0001420720-26-000028.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001420720-26-000028 |
| 2026-09-04 | 20:05 ET | [DEF 14A](/filings/0001420720-26-000022.md) | Proxy statement, period 2026-09-04 | 0001420720-26-000022 |
| 2026-08-28 | 12:32 ET | [10-K](/filings/0001420720-26-000020.md) | Annual report, period 2026-06-30 | 0001420720-26-000020 |
| 2026-08-28 | 12:30 ET | [8-K](/filings/0001420720-26-000019.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001420720-26-000019 |
| 2026-08-04 | 11:05 ET | [8-K](/filings/0001420720-26-000014.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001420720-26-000014 |
| 2026-07-17 | 20:08 ET | [8-K](/filings/0001420720-26-000012.md) | 5.08 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001420720-26-000012 |
| 2026-07-01 | 11:33 ET | [8-K](/filings/0001420720-26-000010.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001420720-26-000010 |
| 2026-05-12 | 20:18 ET | [10-Q](/filings/0001104659-26-059416.md) | Quarterly report, period 2026-03-31 | 0001104659-26-059416 |
| 2026-05-12 | 20:15 ET | [8-K](/filings/0001104659-26-059408.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-059408 |
| 2026-05-08 | 20:16 ET | [8-K](/filings/0001104659-26-057945.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-057945 |
| 2026-04-17 | 21:13 ET | [8-K/A](/filings/0001104659-26-044969.md) | 8.01 Other events | 0001104659-26-044969 |
| 2026-04-08 | 13:00 ET | [8-K](/filings/0001104659-26-040703.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-040703 |
| 2026-03-09 | 11:04 ET | [8-K](/filings/0001420720-26-000006.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001420720-26-000006 |
| 2026-02-27 | 21:49 ET | [8-K](/filings/0001104659-26-021654.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-021654 |
| 2026-02-10 | 21:16 ET | [10-Q](/filings/0001420720-26-000004.md) | Quarterly report, period 2025-12-31 | 0001420720-26-000004 |
| 2026-02-10 | 21:06 ET | [8-K](/filings/0001420720-26-000003.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001420720-26-000003 |
| 2026-01-12 | 22:29 ET | [8-K](/filings/0001104659-26-002940.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-002940 |
| 2025-11-21 | 13:09 ET | [8-K](/filings/0001104659-25-114800.md) | 5.07 Shareholder vote results | 0001104659-25-114800 |
| 2025-11-17 | 21:32 ET | [8-K](/filings/0001420720-25-000045.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001420720-25-000045 |
| 2025-11-17 | 12:40 ET | [10-Q/A](/filings/0001420720-25-000043.md) | Quarterly report, amended, period 2025-09-30 | 0001420720-25-000043 |
| 2025-11-12 | 21:14 ET | [10-Q](/filings/0001420720-25-000041.md) | Quarterly report, period 2025-09-30 | 0001420720-25-000041 |
| 2025-11-12 | 21:05 ET | [8-K](/filings/0001420720-25-000039.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001420720-25-000039 |
| 2025-11-04 | 21:03 ET | [8-K](/filings/0001420720-25-000035.md) | 8.01 Other events | 0001420720-25-000035 |
| 2025-10-30 | 11:29 ET | [8-K](/filings/0001420720-25-000033.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001420720-25-000033 |
| 2025-10-06 | 21:15 ET | [DEF 14A](/filings/0001104659-25-097166.md) | Proxy statement, period 2025-11-20 | 0001104659-25-097166 |
| 2025-09-05 | 13:30 ET | [10-K](/filings/0001558370-25-011888.md) | Annual report, period 2025-06-30 | 0001558370-25-011888 |
| 2025-09-05 | 13:00 ET | [8-K](/filings/0001558370-25-011885.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-011885 |
| 2025-08-21 | 20:11 ET | [8-K](/filings/0001104659-25-081419.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-081419 |
| 2025-08-18 | 20:24 ET | [8-K](/filings/0001104659-25-079816.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-079816 |
| 2025-08-01 | 20:47 ET | [8-K](/filings/0001558370-25-009992.md) | 3.01 Delisting notice | 0001558370-25-009992 |
| 2025-06-24 | 11:56 ET | [8-K](/filings/0001420720-25-000029.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001420720-25-000029 |
| 2025-06-18 | 11:22 ET | [8-K](/filings/0001420720-25-000027.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001420720-25-000027 |
| 2025-05-02 | 12:29 ET | [10-Q](/filings/0001420720-25-000025.md) | Quarterly report, period 2025-03-31 | 0001420720-25-000025 |
| 2025-05-02 | 12:05 ET | [8-K](/filings/0001420720-25-000024.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001420720-25-000024 |
| 2025-04-22 | 20:41 ET | [8-K](/filings/0001420720-25-000020.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001420720-25-000020 |
| 2025-04-08 | 11:30 ET | [8-K](/filings/0001420720-25-000018.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001420720-25-000018 |
| 2025-04-07 | 11:01 ET | [8-K](/filings/0001420720-25-000016.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001420720-25-000016 |
| 2025-02-19 | 21:25 ET | [8-K](/filings/0001420720-25-000014.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001420720-25-000014 |
| 2025-02-10 | 21:15 ET | [10-Q](/filings/0001420720-25-000012.md) | Quarterly report, period 2024-12-31 | 0001420720-25-000012 |
| 2025-02-10 | 21:06 ET | [8-K](/filings/0001420720-25-000010.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001420720-25-000010 |
| 2025-01-13 | 12:55 ET | [8-K](/filings/0001420720-25-000005.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001420720-25-000005 |
| 2025-01-10 | 12:47 ET | [8-K](/filings/0001420720-25-000003.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001420720-25-000003 |
| 2025-01-02 | 12:36 ET | [8-K](/filings/0001420720-25-000001.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001420720-25-000001 |
| 2024-11-25 | 13:30 ET | [8-K](/filings/0001104659-24-122387.md) | 2.02 Results of operations; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-24-122387 |
| 2024-11-12 | 21:27 ET | [10-Q](/filings/0001420720-24-000054.md) | Quarterly report, period 2024-09-30 | 0001420720-24-000054 |
| 2024-11-12 | 21:06 ET | [8-K](/filings/0001420720-24-000053.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001420720-24-000053 |
| 2024-10-23 | 13:12 ET | [8-K](/filings/0001420720-24-000049.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001420720-24-000049 |
| 2024-10-10 | 20:10 ET | [DEF 14A](/filings/0001420720-24-000046.md) | Proxy statement, period 2024-10-10 | 0001420720-24-000046 |

Page 1 of 8. [Older](/companies/ibio/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.